Press Releases

HARTFORD, Conn., Feb. 3, 2020 /PRNewswire/ -- In a medical emergency, anyone can be rattled enough to forget important details, finding themselves unable to answer physicians' important questions about their health or that of a loved one. Anne McAwley-LeDuc, a retired nurse practitioner (APRN), learned this the hard way after h

HAMILTON, N.J., Feb. 3, 2020 /PRNewswire/ -- Genesis Biotechnology Group ("GBG") was subject to a recent malware attack. The attack was limited to the internal research work of a GBG member company engaged in contract research using non-human models to support drug discovery. To carry out its research, this organization does not require, obtain or maintain a

TAMPA, Fla., Feb. 3, 2020 /PRNewswire/ -- Tampa General Hospital is partnering with Agathos to provide a transparency platform that offers actionable, clinical feedback directly to physicians. This unique technology generates clinical insights designed to improve patient outcomes. "Our patients are our number one priority. It's critical for our physicians to have

SANTA MONICA, Calif., Feb. 3, 2020 /PRNewswire/ -- Dr. Christie Prendergast is an unconventional Double Board-Certified Plastic

CARDIFF, Wales, Feb. 3, 2020 /PRNewswire/ -- The recent publication in the journal Frontiers in Bioengineering and biotechnology titled 'Marine Collagen Substrates for 2D and 3D Ovarian Cancer Cell Systems' has demonstrated that jellyfish collagen provides a reliable in vitro micro-environment for the proliferation and migration of Ovarian cancer cells. (OvC

SOUTH SAN FRANCISCO, Calif., Feb. 3, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced the appointment of Rajiv Patni, M.D., as executive vice president and chief medical officer, effective immediately. Dr. Patni brings to his new role two decades of clinical development and approval experien

NORRISTOWN, Pa., Feb. 3, 2020 /PRNewswire/ -- MRO, a leader in the secure, compliant and efficient exchange of protected health information (PHI), announced today it has been nam

HOLLY SPRINGS, N.C., Feb. 3, 2020 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and pandemic response, today announced that the U.S. Food and Drug Administration (FDA) has approved AUDENZ™ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) to help protect individuals six months of age and older against influenza A (H5N1).1 AUDEN

CARLSBAD, Calif., Feb. 3, 2020 /PRNewswire/ -- Patient Power®, which delivers patient-powered journalism, information and opportunities to engage with and connect to the cancer community, reports that results from the first Patient Power Cancer Clinical Trials Survey show that the majority of patients surveyed were interested in taking part in clinical trials,

TORONTO, Feb. 3, 2020 /PRNewswire/ -- 7D Surgical announced today important additions to its cranial and spinal product lines.  The company has received both 510(k) clearance from the U.S. Food and Drug Administration (FDA) and a medical device license from Health Canada for its Cranial Biopsy Kit, which allows neurosurgeons to use image guidance to accurately